Cold Spring Harbor Laboratory announced a collaboration with the Chan Zuckerberg Initiative focused on the development and expansion of CSHL’s bioRxiv (pronounced “bio-archive”) preprint service, a free platform that enables life science researchers to quickly and easily share drafts of papers before they are published in peer-reviewed research journals.
As the debate around Galleri, the multi-cancer detection test developed by GRAIL Inc., rages on, fueled most recently by the full-steam-ahead support it has received from regulatory and legislative bodies, NCI Director Anthony Letai has turned his attention to the available data.
